EP
VMD icon

Essential Partners’s Viemed Healthcare VMD Stock Holding History

Essential Partners’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.86K Sell
251
-800
-76% -$7.92K ﹤0.01% 1812
2026
Q1 		$9.68K Sell
1,051
-55
-5% -$458 ﹤0.01% 1274
2025
Q4 		$8.22K Sell
1,106
-82
-7% -$562 ﹤0.01% 1236
2025
Q3 		$8.07K Buy
1,188
+1,111
+1,443% +$7.52K ﹤0.01% 1245
2025
Q2 		$532 Buy
+77
New +$523 ﹤0.01% 1684

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Essential Partners's VMD Position: Q2 2026 in Review

Essential Partners reduced its Viemed Healthcare (VMD) stake by 76% in Q2 2026, selling an estimated $7.92K and leaving 251 shares worth $2.86K. The position accounts for ﹤0.01% of the portfolio, ranked #1812.

Essential Partners first reported a position in VMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $9.68K in Q1 2026. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Essential Partners held 251 shares of Viemed Healthcare worth $2.86K as of Q2 2026.
  • Essential Partners sold 800 Viemed Healthcare shares in Q2 2026, an estimated $7.92K.
  • Viemed Healthcare made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1812 holding.
  • Essential Partners first reported a position in Viemed Healthcare in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Viemed Healthcare position peaked at $9.68K in Q1 2026.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.